Anaesthesia machine failure requires rapid solutions to maintain ventilation and anaesthesia. During procedures with poor access to the patient's airway, it may not be possible to use a self-inflating mechanical ventilation device (SIMVD) for emergency ventilation, and alternative solutions are needed. We evaluated five methods for rescue ventilation using a patient simulator. In Method 1, we used the inspiratory and expiratory tubes and the alternative common gas outlet (ACGO) on the anaesthesia machine to produce a Mapleson E system. In Method 2, we used the tubes, ACGO and an open-ended reservoir bag to produce a Mapleson F system, controlling the bag to achieve ventilation. In Method 3, we attached a SIMVD to the inspiratory tube, and controlled occlusion of the expiratory tube. In Method 4, we used the tubes and ACGO in a Mapleson F configuration, replacing the open-ended bag with a SIMVD to facilitate manual ventilation. In Method 5, we attached a SIMVD to the expiratory tube and left the inspiratory tube attached to its mounting. We were able to achieve ventilation, maintain inhalational anaesthesia, and prevent expired gas rebreathing in Methods 1 and 2. In Method 3 ventilation was achieved with minimal rebreathing of expiratory gas, but with no inhalational agent. Methods 4 and 5 led to rebreathing. Our findings indicate that Methods 1 or 2 are the preferred rapid solutions to maintain ventilation and inhalational anaesthesia in the event of anaesthesia machine failure where there is poor airway access.
The use of a self-inflating mechanical ventilation device (SIMVD) is the first response when malfunction of the anaesthesia machine breathing circuit occurs during anaesthesia. This requires rapid access to the patient's airway in order to attach the SIMVD to the tracheal tube, supraglottic device or facemask. Such access is limited or delayed during head and neck surgery, if the patient's head is positioned away from the anaesthesia machine, if the patient is prone, and where there are surgical drapes covering up the head and neck. This will make it difficult or impossible to use the SIMVD. It will also be difficult to continue inhalational anaesthesia if the SIMVD is connected to an alternative oxygen source that is separated from the vaporiser pathway.
In a case report by Seif and Olympio, the authors attached a SIMVD to the expiratory limb of the circle breathing circuit to ventilate a patient while resolving a major leak caused by changing the carbon dioxide (CO 2 ) absorbent canister during anaesthesia 1 . The gas flow in the expiratory tube was retrograde during the inspiratory phase and there was mixing with 800 ml of dead space gas in the expiratory tube. This method enabled life-saving oxygenation during that crisis, but CO 2 may accumulate due to the substantial volume of apparatus dead space. In that case report, the problem was solved in nine minutes with the fast resupply of a fresh canister, and a sufentanil infusion was continued during the crisis.
We evaluated solutions for such malfunction of the anaesthesia machine where there is no immediate access to the patient's airway or patient end of the breathing circuit. We tested solutions that could prevent rebreathing of CO 2 and also enable inhalational anaesthesia to continue.
Methods
We carried out our evaluation in a dedicated healthcare simulation facility, using a Human Patient Simulator (HPS® Anaesthesia Model, CAE Healthcare, Sarasota, FL, USA). The HPS was able to simulate human respiratory physiology and gas exchange. The tracheal tube on the simulator was connected to the Y connection of a circle anaesthesia breathing system. The 'exhaled' carbon dioxide from the simulator was measured by a gas analyser (Carescape ™ monitor B850, GE Healthcare, Waukesha, WI, USA) which displayed the capnograph. Rebreathing of exhaled gases could be detected by a rising inspired CO 2 concentration. We conducted our tests with the simulator's Standard Man program, with body weight 70 kg, normal respiratory physiological parameters, and applied 100% neuromuscular blockade. We aimed to maintain the minute ventilation (MV) at 6 l/minute and normocapnia with all the methods tested. We recorded the fraction of inspired (FiCO 2 ) and end-tidal CO 2 (ETCO 2 ) with all methods after ten minutes of ventilation.
We used an anaesthetic machine with integrated standard auxiliary common gas outlet (Aespire® View, GE Healthcare, Madison, WI, USA) with a standard circle breathing circuit and 150 cm extension tubes to simulate the circuit used when the patient's head is at the far end of the operating table. The alternative common gas outlet (ACGO) of the anaesthesia machine was activated by a lever to divert the fresh gas supply to this outlet, to which Mapleson breathing systems could be connected. We simulated anaesthesia machine failure by partially releasing the absorbent canister from its mounting. This resulted in a large leak that could not be compensated for despite maximum fresh gas flow (FGF).
In Method 1, using the existing circle breathing system and ACGO, we produced a Mapleson E system (Figures 1A and 1B); also called the Ayre's T-piece 2,3,4 . The inspiratory and expiratory tubes remained attached to the Y connector at the 'patient' end. We activated the ACGO and then connected the 'machine' end of the inspiratory tube of the circle system to the ACGO. We disconnected the 'machine' end of the expiratory tube, leaving the microbial filter at the end of the expiratory tube. Next we increased the FGF and intermittently occluded the expiratory tube with one hand to produce positive pressure ventilation with this system. We used a FGF of 15 l/minute and a 2 second occlusion time of the expiratory tube to generate a tidal volume of 500 ml. The 'expired' gases were vented from the expiratory tube by releasing hand occlusion of the expiratory tube in the 4 second expiratory phase. This configuration is similar to the "mechanical thumb" ventilators using a Mapleson E configuration. To generate the next breath, the expiratory tube was occluded again and the cycle continued. We were able to continue delivery of inhalational anaesthesia. We tested this method for 15 minutes to check for a rise in FiCO 2 that would indicate the rebreathing of expired gases.
In Method 2, we produced a Mapleson F system by modifying the Mapleson E in Method 1 5, 6 . Using the reservoir bag from the circle system, we cut off the tip of the bag, and attached it to the 'machine' end of the expiratory tube, distal to the microbial filter (Figures 2A and 2B ). This Mapleson F configuration is also called the Jackson Rees modification of the Ayre's T-piece. The bag enabled better control of positive pressure ventilation, and tidal volumes could be produced without the need for a very high FGF. Positive end-expiratory pressure (PEEP) could be produced by regulating the amount of 'expired' gases vented through the hole in the bag. We were able to continue delivery of sevoflurane with this configuration.
In Method 3, we used a SIMVD (Laerdal Silicone Resuscitator, Laerdal Medical, Stavanger, Norway). At the 'machine' end, we disconnected the inspiratory and expiratory tubes of the circle system; the SIMVD was attached to the inspiratory tube and the expiratory tube opening was Figure 1B: Mapleson E system: The expiratory tube is occluded by hand during the inspiratory phase, to direct fresh gas to patient. The expiratory tube is not occluded during the expiratory phase to allow exhaled gases to leave the system. controlled and occluded by the operator (see Figures 3A and  3B ). In the inspiratory phase, the SIMVD was squeezed and the operator occluded the expiratory tube with his hand. This enabled the gas from the SIMVD to enter the patient's lungs and not escape out of the expiratory tube. During expiration, we released the occlusion of the expiratory tube, allowing the 'expired' gases to leave the system through the expiratory tube opening. During expiration, we released the occlusion of the expiratory tube to vent the 'expired' gases.
As the one-way valves of the SIMVD cause higher resistance to retrograde gas flow into the inspiratory limb compared to flow through the open expiratory tube during expiration, we anticipated that rebreathing would be minimal. Figure 3B : Operator using SIMVD, with occlusion of the expiratory tube by hand during the inspiratory phase to direct fresh gas to patient. The expiratory tube is not occluded during the expiratory phase, to allow exhaled gas to leave the system.
In Method 4, we used the inspiratory and expiratory tubes in Mapleson F configuration, and substituted the open-ended bag with a SIMVD. This was to facilitate the ease of manual ventilation. Inhalational anaesthesia could still be delivered via the ACGO. There was no need for supplementary oxygen input into the SIMVD. This mimics a Mapleson F system, but without the additional complexity of coordinating the tail and bagging.
In Method 5 we simulated the method described in the earlier case report 1 . As in that report, we left the inspiratory tube unchanged, still attached to its mounting on the anaesthesia machine. We disconnected the expiratory tube from the machine and attached the SIMVD to the expiratory tube, and ventilated the simulator using the SIMVD. We used a FGF of 12 l/minute and tested this method with minute ventilations of 6 and 12 l/minute.
Results
The FiCO 2 and ETCO 2 data after 15 minutes of ventilation with the five methods are presented in Table 1 .
In Method 1 using the Mapleson E configuration, we were able to maintain normocapnia throughout the trial with no rebreathing of expired gases at a FGF of 2.5 times MV. At a FGF equal to MV, there was a marked reduction in tidal volume to 250 ml, with a rise in ETCO 2 after 15 minutes, but no rebreathing of expired gas.
In Method 2 using the Mapleson F configuration, we could generate larger tidal volumes in a short inspiratory time, without the need for very high FGF. Controlling the openended bag with one hand required some skill but was much easier using two hands. There was some rebreathing of expired gases when FGF was equal to MV, and no rebreathing when FGF was increased to two times MV.
In Method 3, using the SIMVD and a FGF of 6 l/minute, we were able to achieve MV of 6 l/minute and normal ETCO 2 with very low inspired CO 2 (FiCO 2 ≤3 mmHg), indicating minimal rebreathing. An advantage of this method is that in the absence of an ACGO or complete machine failure with no FGF, ventilation with the SIMVD can still continue with oxygen from a cylinder or even using room air. However, intravenous anaesthetic administration would be required to maintain anaesthesia.
In Method 4, at a minute volume of 6 l/minute and 6 l/ minute FGF, there is a significant amount of rebreathing due to an insufficient amount of fresh gas flow to wash out the dead space gases and the slight resistance provided by the expiratory valve in the SIMVD, leading to hypercarbia. At 12 l/minute FGF, rebreathing drops significantly. However, when MV is increased to 12 l/minute, rebreathing occurs again due to insufficient time for apparatus dead space gases to be washed out. With this variation of the Mapleson F configuration using a SIMVD on the expiratory limb, manual ventilation with the SIMVD was easier compared to with an open-ended bag. In Method 5 simulating the case report by using the SIMVD on the expiratory tube, there was a large increase in apparatus dead space, along the entire expiratory limb. This resulted in substantial rebreathing of expiratory gases. This caused a rapid increase in the FiCO 2 and the ETCO 2 within 30 seconds which could not be prevented even with a FGF of 12 l/minute and minute ventilation of 12 l/minute.
Discussion
In an emergency situation with an anaesthetic machine failure, oxygenation is the priority and ventilation with 100% oxygen by any means should always be attempted first. The Mapleson E and F configurations described here enabled oxygenation without rebreathing of expired gases as well as continued administration of inhalational anaesthesia. Both configurations require the anaesthetic machine to have an ACGO where fresh gas flow can be directed, while turning off the gas supply to the faulty circle system.
As high FGFs are used, there can be rapid changes in the inspired anaesthetic concentrations. The composition of the inspired gas is determined by the FGF, the patient's CO 2 production, respiratory pattern, and the amount of rebreathing of expiratory gas, making the exact composition difficult to predict. A limitation of this study is that the simulator was not able to simulate patient uptake of inhalational anaesthetic agents. We suggest that in an actual patient, the anaesthetic concentrations can be measured by the gas analyser connected close to the patient's airway, and the FGF and ventilation pattern adjusted accordingly.
Rebreathing of expired CO 2 is a concern with the Mapleson systems. It is difficult to predict the extent of mixing of fresh and expired gas in the expiratory tube, and FGFs that completely prevent rebreathing. During controlled ventilation, a long expiratory time can improve removal of exhaled alveolar gases from the system. Rebreathing can be minimised by high FGF. It can be detected by the presence of CO 2 in the inspiratory phase of the capnograph, and this can guide the FGF used. Perhaps more important than a low FiCO 2 is the adequacy of alveolar ventilation and CO 2 removal, which can be monitored with the ETCO 2 . An increase in the ETCO 2 at adequate minute ventilation suggests that the FGF needs to be increased.
The Mapleson E configuration is simplest with no bag or valves and the fastest to set up. It can also be used during spontaneous ventilation. If the volume of the expiratory tube is larger than patient's tidal volume and adequate FGF is used, inspiration of room air is minimised during spontaneous ventilation. In controlled ventilation, a higher FGF will enable generation of a desired tidal volume within a shorter inspiratory time or a larger tidal volume within the same inspiratory time. With capnography, the FGF could be adjusted to prevent rebreathing with the different respiratory patterns and minute volumes. In the absence of capnography and gas analysis, it is still possible to minimise rebreathing by using high FGF of 2.5 times the predicted minute ventilation. A potential disadvantage of the Mapleson E is barotrauma if occlusion of the expiratory tube is excessively prolonged at high FGF.
The Mapleson F configuration can also be used during spontaneous and controlled ventilation. Spontaneous ventilation can be monitored by the spontaneous filling and emptying of the reservoir bag. By adjusting the venting of expired gases and squeezing the bag, higher inspiratory pressures can be produced to overcome any reduction in lung and chest wall compliance and deliver adequate tidal volume. PEEP can also be applied if needed. FGFs of 100 ml/ kg/minute have been predicted to prevent rebreathing during controlled ventilation, and higher flows are required during spontaneous ventilation. The composition of the inspired gas can vary from pure fresh gas to a combination of fresh and expired gas. If rebreathing of expired gas occurs in the later phase of inspiration, this gas would fill the anatomical dead space, not the alveoli, and should not affect CO 2 removal from the alveoli. This feature can be employed to reduce the fresh gas requirement to 70 ml/kg/minute, and improve its efficiency. Using a SIMVD instead of the open-ended bag as in Method 4 may make use of this configuration easier, but high FGFs are required.
The advantage of Method 3 using a SIMVD is that an ACGO is not needed. In a complete machine failure with no functioning oxygen source, ventilation can still be maintained with room air. A disadvantage is that there is no inhalational anaesthesia agent when the gas source is from an auxiliary oxygen flowmeter or from a cylinder. Total intravenous anaesthesia (TIVA) would be needed to maintain anaesthesia and this would require assistance to prepare and start in such an emergency. If there is an ACGO on the machine, the gas intake of the SIMVD can be connected to the ACGO, and the fresh gas composition adjusted to maintain adequate inspired concentrations of inhalational anaesthetic. For both spontaneous and controlled ventilation, coordination to occlude the expiratory tube during inspiration is needed.
Methods 1 to 4 do not increase the existing apparatus dead space of a working circle system. This dead space comprises the patient limb of the Y connection, any intermediate catheter connector and the tracheal tube. This is unlike Method 5, which was used in the earlier case report, where there was significant mixing of FGF and expired gases in the expiratory tube.
A limitation of these methods is that they require much higher FGFs compared to a functioning circle system with CO 2 absorption. Efficiency can be improved by using the lowest FGF that prevents rebreathing of expired alveolar gases. Secondly, these rescue methods lack scavenging connections and will pollute the operating theatre. This is inevitable in an emergency, but it may be possible to channel the expired gases to the scavenging system in the anaesthesia machine, once adequate oxygenation and ventilation are achieved. Changing to total intravenous anaesthesia will also prevent such pollution. Thirdly, there is no humidification or warming of the inspired gases. We have only tested these solutions in a simulator using a standard adult module, rather than in patients, for ethical reasons.
As the circle breathing circuit system is the default setup in modern anaesthetic machines, the Mapleson systems are less frequently used in current practice. However, an understanding of the Mapleson systems may still have value during emergencies. In this evaluation, the Mapleson systems we configured are viable solutions when access to the patient's end of the breathing system is limited during anaesthetic machine failure. Pre-emptive training on the management of this situation using simulators may give anaesthetists and trainees a better understanding of the setup and ventilation techniques with these solutions. With deliberate practice, guided feedback and self-reflection, trainees can work through the problem in a safe environment and develop the competency to employ these solutions in real emergencies 7 .
In summary, we report five possible rapid solutions for rescue in an anaesthesia machine failure crisis where there is no access to the patient's airway and the 'patient' end of the breathing system. We were able to achieve ventilation, maintain delivery of inhalational anaesthesia, and prevent expired gas rebreathing in Methods 1 and 2. In Method 3 ventilation was achieved with minimal rebreathing of expiratory gas, but with no inhalational agent. Methods 4 and 5 led to rebreathing. Our findings indicate that Methods 1 or 2 are the preferred rapid solutions to maintain ventilation and inhalational anaesthesia in the event of anaesthesia machine failure where there is poor airway access.
